Leonardo BioSystems, Inc. and NanoMedical Systems Sign Collaboration Deal for Manufacturing Scale Up of Leonardo’s Drug Delivery Nanoparticles

HOUSTON & AUSTIN, Texas.--(BUSINESS WIRE)--Leonardo Biosystems, Inc. and NanoMedical Systems, Inc. (NMS), two emerging drug delivery companies, today announced that they have signed a development contract in which NMS will develop and establish a commercial process to manufacture nanoporous silicon particles for Leonardo’s multi-stage drug delivery system.